Angiopoietin-2 and CRP in Colorectal Cancer
Author Information
Author(s): Volkova E, Willis J A, Wells J E, Robinson B A, Dachs G U, Currie M J
Primary Institution: University of Otago Christchurch
Hypothesis
Obesity-related chronic hyperinsulinemia and insulin resistance promote a pro-inflammatory and pro-angiogenic environment that stimulates tumour growth and metastasis, leading to poor survival.
Conclusion
The study confirms serum Ang-2 as a predictive marker for the outcome of colorectal cancer.
Supporting Evidence
- Serum Ang-2 and VEGF-A levels increased with tumor T stage.
- Patients with high serum levels of CRP and Ang-2 had significantly reduced survival.
- Ang-2 remained a significant predictor of survival after adjusting for tumor stage and age.
Takeaway
This study found that inflammation from obesity is linked to worse outcomes in colorectal cancer, and high levels of a protein called Ang-2 can help predict survival.
Methodology
Clinical and pathological data were collected from 344 colorectal cancer patients, and serum samples were analyzed for various markers.
Limitations
The study did not determine waist circumference, and the small number of patients with type 2 diabetes may limit the findings.
Participant Demographics
The cohort included 173 males and 171 females, with ages ranging from 31 to 91 years, and 20% were AJCC stage I, 42% stage II, 34% stage III, and 4% stage IV.
Statistical Information
P-Value
P=0.007 for Ang-2 and P=0.025 for VEGF-A with tumor T stage.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website